Novasenta Inc. is a U.S. startup biotech company headquartered in Pittsburgh, Pennsylvania, focused on the discovery and validation of novel biological targets to develop advanced cancer treatments.
Subscribe to see Novasenta Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Novasenta Inc. is a company headquartered in United States. Its most recent funding round raised $15M in December 2023. Xcout tracks 11 named people at Novasenta Inc., including Michael Lyman, PhD (CEO).
5 more named people on record for Novasenta Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $15M | — | |
| SEC Form D filing | $10M | — | |
| Series A | $40M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Novasenta Inc.'s closest competitors — see the full list of competitors and alternatives →
MetasTx Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, focused on creating novel therapeutics to treat diseases.
Duo Oncology Inc. is a United States-based company located in Pittsburgh, Pennsylvania, specializing in stroma-penetrating nanomedicine to improve cancer treatments.
Western Oncolytics Ltd. is a cutting-edge biotechnology and pharmaceutical company headquartered in Pittsburgh, Pennsylvania, focused on developing novel cancer therapies and drug pipelines.
BlueSphere Bio, Inc. is a biotechnology company headquartered in Pittsburgh, Pennsylvania, focused on advancing cellular therapies and oncology research.
Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Pittsburgh, Pennsylvania. Founded in 2000, the company focuses on developing next-generation biologic therapeutics derived from multicellular secretomes for various clinical indications.
Novita Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in New York, New York, dedicated to developing first-in-class drugs to prevent and treat cancer.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.